HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brad Millson Selected Research

Brad Millson Research Topics

Disease

2Arthritis (Polyarthritis)
10/2022 - 09/2019
1Type 2 Diabetes Mellitus (MODY)
07/2023
1COVID-19
07/2023
1Diabetes Complications
07/2023
1Pneumonia (Pneumonitis)
03/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Herpes Zoster
01/2021
1Chronic Renal Insufficiency
01/2021
1Rheumatoid Arthritis
11/2019
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
09/2019
1Necrosis
12/2018
1Crohn Disease (Crohn's Disease)
12/2018
1Rheumatic Diseases (Rheumatism)
09/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
09/2018
1Ankylosing Spondylitis
06/2018
1Autoimmune Diseases (Autoimmune Disease)
06/2018

Drug/Important Bio-Agent (IBA)

3Etanercept (Enbrel)FDA Link
11/2019 - 09/2018
2Methotrexate (Mexate)FDA LinkGeneric
11/2019 - 09/2019
2Prednisone (Sone)FDA LinkGeneric
11/2019 - 09/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019 - 06/2018
2Adalimumab (Humira)FDA Link
12/2018 - 06/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2023
1secukinumabIBA
10/2022
1tocilizumab (atlizumab)FDA Link
10/2022
1golimumabFDA Link
10/2022
1tofacitinibIBA
10/2022
1apremilastIBA
10/2022
1Abatacept (Orencia)FDA Link
10/2022
1Ustekinumab (CNTO 1275)FDA Link
10/2022
1Herpes Zoster VaccineIBA
01/2021
1CreatinineIBA
01/2021
1SteroidsIBA
09/2019
1Tumor Necrosis Factor InhibitorsIBA
09/2019

Therapy/Procedure

2Therapeutics
10/2022 - 11/2019
1Continuity of Patient Care
07/2023
1Length of Stay
03/2023
1Biological Therapy
12/2018